This segment focuses on the research, development, manufacturing, and commercialization of traditional Chinese medicine products. Kangmei utilizes advanced extraction and formulation techniques to produce a wide range of TCM preparations, including herbal raw materials, patent medicines, and health supplements. Research and development activities include the study of herbal medicine efficacy, standardization of TCM formulas, and the development of new TCM products for various therapeutic areas. The company's market positioning is strong in China, leveraging its established brand and distribution network. Future opportunities lie in expanding its product portfolio, exploring international markets, and integrating modern scientific methods with traditional practices. This segment addresses a wide range of health conditions, with a focus on improving overall wellness and treating chronic diseases. Regulatory compliance and quality assurance are critical aspects of this segment, ensuring the safety and efficacy of TCM products. Partnerships with healthcare providers and research institutions are key to innovation and market expansion.

This segment involves the production and sale of chemical drug products, including both generic and specialty pharmaceuticals. Kangmei's R&D efforts in this area focus on developing new formulations, improving drug delivery systems, and conducting clinical trials to demonstrate efficacy and safety. The company utilizes advanced manufacturing technologies to ensure high-quality production and adheres to stringent regulatory standards. The therapeutic areas covered include treatments for hypertension and colds, among others. The patient impact is significant, as these drugs address common and critical health issues. Market positioning is competitive, requiring continuous innovation and cost-effectiveness. Future opportunities include expanding the product portfolio, entering new therapeutic areas, and exploring partnerships for drug development and commercialization. Regulatory compliance, including FDA approval processes, is a key aspect of this segment. Clinical trials and evidence-based medicine are crucial for demonstrating the value of these products.

This segment encompasses the operation of hospitals and Chinese medicine pharmacies. Kangmei provides comprehensive healthcare services, including diagnosis, treatment, and dispensing of medications. The company invests in modern medical equipment and facilities to provide high-quality patient care. Research and development activities include the study of new treatment modalities, the development of personalized medicine approaches, and the integration of technology to improve patient outcomes. The therapeutic areas covered include a wide range of medical specialties. The patient impact is significant, as the segment provides access to healthcare services and improves the overall health of the population. Market positioning is based on providing quality care and building a strong reputation. Future opportunities include expanding the network of hospitals and pharmacies, adopting telemedicine and digital health solutions, and exploring partnerships with other healthcare providers. Regulatory compliance and patient safety are paramount in this segment. The company focuses on providing accessible and affordable healthcare services.